The Northern District of California recently amended its Local Rules of Practice for Patent Cases. The new rules took effect on January 17, 2017. A number of the modifications relate to the disclosure of damages-related information. To read more, click the link below.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...